137 related articles for article (PubMed ID: 27416567)
21. Red cell alloimmunisation in oncology patients: A study from eastern India.
Dhar S; Basu S
Transfus Apher Sci; 2015 Jun; 52(3):345-9. PubMed ID: 25818996
[TBL] [Abstract][Full Text] [Related]
22. Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease.
Rankin A; Darbari D; Campbell A; Webb J; Mo YD; Jacquot C; Delaney M; Luban NLC; Nickel RS
Transfusion; 2021 Aug; 61(8):2255-2264. PubMed ID: 34002408
[TBL] [Abstract][Full Text] [Related]
23. Red blood cell alloimmunization in transfused patients with bone marrow failure syndromes.
Cohen D; Hartung H; Evans P; Friedman DF; Chou ST
Transfusion; 2016 Jun; 56(6):1314-9. PubMed ID: 27080340
[TBL] [Abstract][Full Text] [Related]
24. Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching.
Ang AL; Lim CY; Ng WY; Lam JCM
Transfusion; 2021 Sep; 61(9):2566-2577. PubMed ID: 34258773
[TBL] [Abstract][Full Text] [Related]
25. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia.
Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A
Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746
[TBL] [Abstract][Full Text] [Related]
26. Red cell alloimmunisation in patients with different types of infections.
Evers D; van der Bom JG; Tijmensen J; Middelburg RA; de Haas M; Zalpuri S; de Vooght KM; van de Kerkhof D; Visser O; Péquériaux NC; Hudig F; Zwaginga JJ
Br J Haematol; 2016 Dec; 175(5):956-966. PubMed ID: 27539877
[TBL] [Abstract][Full Text] [Related]
27. [Red blood cell alloimmunization among polytransfused patients in the National Hospital and University Center of Cotonou: about 51 cases].
Baglo T; Zohoun A; Agboton BL; Vigan J; Ayaka P; Anani L; Fall AOT; Gazard DK
Pan Afr Med J; 2021; 38():304. PubMed ID: 34178222
[TBL] [Abstract][Full Text] [Related]
28. Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products.
Yazer MH; Triulzi DJ; Sperry JL; Seheult JN
Transfusion; 2021 Jul; 61 Suppl 1():S150-S158. PubMed ID: 34269438
[TBL] [Abstract][Full Text] [Related]
29. Alloimmunisation rates of sickle cell disease patients in the United States differ from those in other geographical regions.
Zheng Y; Maitta RW
Transfus Med; 2016 Jun; 26(3):225-30. PubMed ID: 27197689
[TBL] [Abstract][Full Text] [Related]
30. Determination
Thuku NW; Shikuku K; Mbugua A
Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases.
Natukunda B; Schonewille H; van de Watering L; Brand A
Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889
[TBL] [Abstract][Full Text] [Related]
32. Red-cell alloimmunization profile in multi transfused patients: Findings and insights of a blood transfusion service.
Pereira Bueno ML; Mitestainer MB; Da Silva JAR; Benites BD; Roversi FM
Transfus Clin Biol; 2021 Aug; 28(3):258-263. PubMed ID: 33901640
[TBL] [Abstract][Full Text] [Related]
33. Impact of azacitidine on red blood cell alloimmunisation in myelodysplastic syndrome.
Ortiz S; Orero MT; Javier K; Villegas C; Luna I; Pérez P; Roig M; López M; Costa S; Carbonell F; Collado R; Ivars D; Linares M
Blood Transfus; 2017 Sep; 15(5):472-477. PubMed ID: 27416573
[TBL] [Abstract][Full Text] [Related]
34. Antibodies against human neutrophil antigens in non-transfused women with red blood cell alloimmunisation induced by pregnancy.
Martins JO; Moritz E; Abbas SA; Lopes LB; Barros MMO; Chiba AK; Langhi DM; Bordin JO
Blood Transfus; 2021 Nov; 19(6):479-486. PubMed ID: 33085600
[TBL] [Abstract][Full Text] [Related]
35. HLA polymorphisms and risk of red blood cell alloimmunisation in polytransfused patients with sickle cell anaemia.
Rodrigues C; Sell AM; Guelsin GAS; Higa TT; Pagliarini E Silva S; Macedo LC; Sippert EÂ; de Alencar JB; Zanette Â; Acorsi CRL; Castilho L; Visentainer JEL
Transfus Med; 2017 Dec; 27(6):437-443. PubMed ID: 28881103
[TBL] [Abstract][Full Text] [Related]
36. Emergency transfusion of patients with unknown blood type with blood group O Rhesus D positive red blood cell concentrates: a prospective, single-centre, observational study.
Selleng K; Jenichen G; Denker K; Selleng S; Müllejans B; Greinacher A
Lancet Haematol; 2017 May; 4(5):e218-e224. PubMed ID: 28389344
[TBL] [Abstract][Full Text] [Related]
37. Implementation and outcomes of a transfusion-related acute lung injury surveillance programme and study of HLA/HNA alloimmunisation in blood donors.
Porretti L; Cattaneo A; Coluccio E; Mantione E; Colombo F; Mariani M; Bottelli G; Mazzucchelli S; Pappalettera M; Speranza T; Migliari M; Cambié G; Prati D; Rebulla P
Blood Transfus; 2012 Jul; 10(3):351-9. PubMed ID: 22395353
[TBL] [Abstract][Full Text] [Related]
38. Red cell immunization in multiply transfused Malay thalassemic patients.
Noor Haslina MN; Ariffin N; Illuni Hayati I; Rosline H
Southeast Asian J Trop Med Public Health; 2006 Sep; 37(5):1015-20. PubMed ID: 17333748
[TBL] [Abstract][Full Text] [Related]
39. Red blood cell alloimmunisation in sickle cell disease patients in the Democratic Republic of the Congo.
Kambale-Kombi P; Djang'eing'a RM; Alworong'a Opara JP; Minon JM; Sepulchre E; Bours V; Floch A; Pirenne F; Tshilumba CK; Batina-Agasa S
Transfus Med; 2023 Apr; 33(2):137-146. PubMed ID: 36377544
[TBL] [Abstract][Full Text] [Related]
40. Complete RH and Kell matching related to low alloimmunisation risk in sickle cell disease: prevalence and risk factors of alloimmunisation in a Spanish Tertiary Care National Reference Centre.
Regalado-Artamendi I; Pérez-Corral AM; García-Morín M; Cela E; Beléndez C; Bardón-Cancho EJ; Pérez-Rus G; Pérez-Sánchez I; Pascual C; Monsalvo S; Falero C; Díez-Martín JL; Anguita J
Blood Transfus; 2021 Jul; 19(4):292-299. PubMed ID: 33085598
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
